tiprankstipranks
Trending News
More News >
Denali Therapeutics (DNLI)
NASDAQ:DNLI
US Market

Denali Therapeutics (DNLI) Income Statement

Compare
701 Followers

Denali Therapeutics Income Statement

Last quarter (Q1 2025), Denali Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Denali Therapeutics's net income was $-132.97M. See Denali Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 330.53M$ 108.46M$ 48.66M$ 335.66M
Gross Profit
$ 0.00$ 313.81M$ 101.43M$ 43.05M$ 123.04M
Operating Expenses
$ 501.88M$ 527.23M$ 449.21M$ 344.41M$ 272.94M
Depreciation and Amortization
$ 7.79M$ 16.73M$ 7.03M$ 5.61M$ 6.17M
EBITDA
$ -414.91M$ -179.97M$ -330.36M$ -287.16M$ 62.72M
Operating Income
$ -487.34M$ -196.70M$ -340.74M$ -295.75M$ 62.72M
Other Income/Expenses
$ 64.64M$ 51.51M$ 14.77M$ 4.59M$ 9.24M
Pretax Income
$ -422.70M$ -145.19M$ -325.97M$ -291.16M$ 71.96M
Net Income
$ -422.77M$ -145.22M$ -325.99M$ -290.58M$ 71.14M
Per Share Metrics
Basic EPS
$ -2.57$ -1.06$ -2.60$ -2.39$ 0.65
Diluted EPS
$ -2.57$ -1.06$ -2.60$ -2.39$ 0.63
Weighted Average Shares Outstanding
164.47M 137.37M 125.53M 121.52M 108.97M
Weighted Average Shares Outstanding (Diluted)
164.47M 137.37M 125.53M 121.52M 112.70M
Currency in USD

Denali Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis